Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of the novel deletion-type PML-RARA mutation associated with the retinoic acid resistance in acute promyelocytic leukemia.
Hattori H, Ishikawa Y, Kawashima N, Akashi A, Yamaguchi Y, Harada Y, Hirano D, Adachi Y, Miyao K, Ushijima Y, Terakura S, Nishida T, Matsushita T, Kiyoi H. Hattori H, et al. Among authors: adachi y. PLoS One. 2018 Oct 5;13(10):e0204850. doi: 10.1371/journal.pone.0204850. eCollection 2018. PLoS One. 2018. PMID: 30289902 Free PMC article.
Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantation.
Goto T, Murata M, Nishida T, Terakura S, Kamoshita S, Ishikawa Y, Ushijima Y, Adachi Y, Suzuki S, Kato K, Hirakawa A, Nishiwaki S, Nishio N, Takahashi Y, Kodera Y, Matsushita T, Kiyoi H. Goto T, et al. Among authors: adachi y. Stem Cells Transl Med. 2021 Apr;10(4):542-553. doi: 10.1002/sctm.20-0381. Epub 2020 Dec 14. Stem Cells Transl Med. 2021. PMID: 33314650 Free PMC article. Clinical Trial.
Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol.
Goto T, Murata M, Terakura S, Nishida T, Adachi Y, Ushijima Y, Shimada K, Ishikawa Y, Hayakawa F, Nishio N, Nishiwaki S, Hirakawa A, Kato K, Takahashi Y, Kiyoi H. Goto T, et al. Among authors: adachi y. Medicine (Baltimore). 2018 Apr;97(17):e0449. doi: 10.1097/MD.0000000000010449. Medicine (Baltimore). 2018. PMID: 29702996 Free PMC article. Clinical Trial.
A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells with FLT3 mutations.
Yamaura T, Nakatani T, Uda K, Ogura H, Shin W, Kurokawa N, Saito K, Fujikawa N, Date T, Takasaki M, Terada D, Hirai A, Akashi A, Chen F, Adachi Y, Ishikawa Y, Hayakawa F, Hagiwara S, Naoe T, Kiyoi H. Yamaura T, et al. Among authors: adachi y. Blood. 2018 Jan 25;131(4):426-438. doi: 10.1182/blood-2017-05-786657. Epub 2017 Nov 29. Blood. 2018. PMID: 29187377 Free article.
Mutation analysis of therapy-related myeloid neoplasms.
Nishiyama T, Ishikawa Y, Kawashima N, Akashi A, Adachi Y, Hattori H, Ushijima Y, Kiyoi H. Nishiyama T, et al. Among authors: adachi y. Cancer Genet. 2018 Apr;222-223:38-45. doi: 10.1016/j.cancergen.2018.02.006. Epub 2018 Mar 8. Cancer Genet. 2018. PMID: 29666007
2,716 results